Chainalysis reports a $100 million gray market for peptides, driven by rising demand and social media influence, raising safety concerns.
Chainalysis has unveiled a significant rise in the gray market for peptides, with annual on-chain payment volumes exceeding $100 million. The report highlights a staggering 159% increase in funds during the first quarter of 2026, escalating from $12 million to $32 million, and predicts further growth to $39 million by the second quarter.
The growing demand for peptides is linked to the rising prices and limited availability of approved weight-loss drugs like Ozempic. As banking regulations restrict the sale of these products, many transactions have shifted to cryptocurrencies, particularly Bitcoin and stablecoins.
The Influence of Social Media
Experts noted that the peptide market evolved through three phases, remaining niche until 2025 with monthly revenues averaging $200,000. A surge in interest coincided with political events in the U.S., particularly Robert F. Kennedy Jr.'s health initiative. However, a viral trend on TikTok within the looksmaxxing community in late 2025 significantly boosted market visibility, leading to average monthly sales of $9.9 million.
Influencers have begun promoting Chinese suppliers without adequately addressing potential health risks, and there is a concerning trend of minors engaging in these communities to evade Know Your Customer (KYC) regulations.
Concerns Over Safety and Regulation
Chainalysis referenced data from the Janoshik laboratory in the Czech Republic, which has received over $12 million in cryptocurrency since 2023 for substance testing. Despite this growth, the cost of testing has dropped by 88%, leading consumers to rely more on self-published certificates of purity. Analysts cautioned that while these documents may confirm purity, they do not guarantee sterility, posing serious health risks.
Connections to Drug Trafficking
The report also revealed that some leading peptide suppliers are Chinese chemical firms with prior ties to drug cartels, particularly in the production of fentanyl and amphetamines. These companies have transitioned to a direct-to-consumer model, which is less legally risky yet more profitable. Notable entities include:
- Shanghai Sigma Audley: Previously linked to fentanyl precursor sales, this company has started marketing cosmetic peptides on Reddit.
- Bigreat Technology: This firm, known for supplying synthetic drug reagents, has pivoted to retail weight-loss products using cryptocurrencies.
Chainalysis emphasized that blockchain technology enables real-time tracking of these illicit supply chains. The volume of cryptocurrency-related money laundering has reportedly surged from $10 billion in 2020 to $82 billion in 2025.
